INT J INFECT DIS 润色咨询

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

出版年份:1996 年文章数:2941 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=949989, encodeId=5c5c949989bf, content=5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Sun Mar 21 21:29:42 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102660, encodeId=2fb8210266076, content=投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Fri Nov 25 22:32:42 CST 2022, time=2022-11-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1224331, encodeId=1391122433133, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染<br>经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f64830584, createdName=263724263, createdTime=Sat Jun 04 02:08:47 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145017, encodeId=1e79214501e9a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:感染学;mNGS<br>经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85a68298213, createdName=ms5000001540302513, createdTime=Tue Jun 27 13:42:09 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578375, encodeId=8cf35e8375b7, content=版面费多少<span class="quote">SSRIs 2014-12-06 10:34:00 发表:<br>中过一篇meta,就是版面费略贵。</span>, beContent=SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTKATfdYUgqMw9NQsiavZ1yfp6nqXs2psvhrv4w9nkv9ZkNrPibvNFjjAjcooyToUBjMt08NnksFDw/132, createdBy=16335154838, createdName=634071814_16358511, createdTime=Wed Oct 23 00:00:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152923, encodeId=83f621529239b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:传染病<br>经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13c8713895, createdName=ms3000000245174331, createdTime=Tue Aug 15 20:34:05 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151570, encodeId=0a4421515e014, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:新冠<br>经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Aug 07 08:21:32 CST 2023, time=2023-08-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143916, encodeId=f6d82143916fe, content=刚投,希望可以送审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=648b5646355, createdName=ms2000001355147229, createdTime=Tue Jun 20 17:15:43 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109115, encodeId=9e772109115a2, content=偏重的研究方向:传染病<br>经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2b8121812, createdName=Lorabetter, createdTime=Fri Jan 06 19:41:12 CST 2023, time=2023-01-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=888810, encodeId=16ca88881092, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:感染;传染病<br>经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1534890747, createdName=2514703170, createdTime=Sun Sep 27 23:18:01 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2021-03-21 803

    5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。

    10

    展开10条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=949989, encodeId=5c5c949989bf, content=5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Sun Mar 21 21:29:42 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102660, encodeId=2fb8210266076, content=投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Fri Nov 25 22:32:42 CST 2022, time=2022-11-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1224331, encodeId=1391122433133, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染<br>经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f64830584, createdName=263724263, createdTime=Sat Jun 04 02:08:47 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145017, encodeId=1e79214501e9a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:感染学;mNGS<br>经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85a68298213, createdName=ms5000001540302513, createdTime=Tue Jun 27 13:42:09 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578375, encodeId=8cf35e8375b7, content=版面费多少<span class="quote">SSRIs 2014-12-06 10:34:00 发表:<br>中过一篇meta,就是版面费略贵。</span>, beContent=SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTKATfdYUgqMw9NQsiavZ1yfp6nqXs2psvhrv4w9nkv9ZkNrPibvNFjjAjcooyToUBjMt08NnksFDw/132, createdBy=16335154838, createdName=634071814_16358511, createdTime=Wed Oct 23 00:00:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152923, encodeId=83f621529239b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:传染病<br>经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13c8713895, createdName=ms3000000245174331, createdTime=Tue Aug 15 20:34:05 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151570, encodeId=0a4421515e014, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:新冠<br>经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Aug 07 08:21:32 CST 2023, time=2023-08-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143916, encodeId=f6d82143916fe, content=刚投,希望可以送审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=648b5646355, createdName=ms2000001355147229, createdTime=Tue Jun 20 17:15:43 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109115, encodeId=9e772109115a2, content=偏重的研究方向:传染病<br>经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2b8121812, createdName=Lorabetter, createdTime=Fri Jan 06 19:41:12 CST 2023, time=2023-01-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=888810, encodeId=16ca88881092, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:感染;传染病<br>经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1534890747, createdName=2514703170, createdTime=Sun Sep 27 23:18:01 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2022-11-25 小月小月 来自湖南省

    投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=949989, encodeId=5c5c949989bf, content=5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Sun Mar 21 21:29:42 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102660, encodeId=2fb8210266076, content=投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Fri Nov 25 22:32:42 CST 2022, time=2022-11-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1224331, encodeId=1391122433133, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染<br>经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f64830584, createdName=263724263, createdTime=Sat Jun 04 02:08:47 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145017, encodeId=1e79214501e9a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:感染学;mNGS<br>经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85a68298213, createdName=ms5000001540302513, createdTime=Tue Jun 27 13:42:09 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578375, encodeId=8cf35e8375b7, content=版面费多少<span class="quote">SSRIs 2014-12-06 10:34:00 发表:<br>中过一篇meta,就是版面费略贵。</span>, beContent=SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTKATfdYUgqMw9NQsiavZ1yfp6nqXs2psvhrv4w9nkv9ZkNrPibvNFjjAjcooyToUBjMt08NnksFDw/132, createdBy=16335154838, createdName=634071814_16358511, createdTime=Wed Oct 23 00:00:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152923, encodeId=83f621529239b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:传染病<br>经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13c8713895, createdName=ms3000000245174331, createdTime=Tue Aug 15 20:34:05 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151570, encodeId=0a4421515e014, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:新冠<br>经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Aug 07 08:21:32 CST 2023, time=2023-08-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143916, encodeId=f6d82143916fe, content=刚投,希望可以送审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=648b5646355, createdName=ms2000001355147229, createdTime=Tue Jun 20 17:15:43 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109115, encodeId=9e772109115a2, content=偏重的研究方向:传染病<br>经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2b8121812, createdName=Lorabetter, createdTime=Fri Jan 06 19:41:12 CST 2023, time=2023-01-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=888810, encodeId=16ca88881092, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:感染;传染病<br>经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1534890747, createdName=2514703170, createdTime=Sun Sep 27 23:18:01 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2022-06-04 263724263

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:感染
    经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=949989, encodeId=5c5c949989bf, content=5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Sun Mar 21 21:29:42 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102660, encodeId=2fb8210266076, content=投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Fri Nov 25 22:32:42 CST 2022, time=2022-11-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1224331, encodeId=1391122433133, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染<br>经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f64830584, createdName=263724263, createdTime=Sat Jun 04 02:08:47 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145017, encodeId=1e79214501e9a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:感染学;mNGS<br>经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85a68298213, createdName=ms5000001540302513, createdTime=Tue Jun 27 13:42:09 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578375, encodeId=8cf35e8375b7, content=版面费多少<span class="quote">SSRIs 2014-12-06 10:34:00 发表:<br>中过一篇meta,就是版面费略贵。</span>, beContent=SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTKATfdYUgqMw9NQsiavZ1yfp6nqXs2psvhrv4w9nkv9ZkNrPibvNFjjAjcooyToUBjMt08NnksFDw/132, createdBy=16335154838, createdName=634071814_16358511, createdTime=Wed Oct 23 00:00:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152923, encodeId=83f621529239b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:传染病<br>经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13c8713895, createdName=ms3000000245174331, createdTime=Tue Aug 15 20:34:05 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151570, encodeId=0a4421515e014, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:新冠<br>经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Aug 07 08:21:32 CST 2023, time=2023-08-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143916, encodeId=f6d82143916fe, content=刚投,希望可以送审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=648b5646355, createdName=ms2000001355147229, createdTime=Tue Jun 20 17:15:43 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109115, encodeId=9e772109115a2, content=偏重的研究方向:传染病<br>经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2b8121812, createdName=Lorabetter, createdTime=Fri Jan 06 19:41:12 CST 2023, time=2023-01-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=888810, encodeId=16ca88881092, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:感染;传染病<br>经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1534890747, createdName=2514703170, createdTime=Sun Sep 27 23:18:01 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2023-06-27 ms5000001540302513 来自广东省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:感染学;mNGS
    经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=949989, encodeId=5c5c949989bf, content=5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Sun Mar 21 21:29:42 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102660, encodeId=2fb8210266076, content=投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Fri Nov 25 22:32:42 CST 2022, time=2022-11-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1224331, encodeId=1391122433133, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染<br>经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f64830584, createdName=263724263, createdTime=Sat Jun 04 02:08:47 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145017, encodeId=1e79214501e9a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:感染学;mNGS<br>经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85a68298213, createdName=ms5000001540302513, createdTime=Tue Jun 27 13:42:09 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578375, encodeId=8cf35e8375b7, content=版面费多少<span class="quote">SSRIs 2014-12-06 10:34:00 发表:<br>中过一篇meta,就是版面费略贵。</span>, beContent=SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTKATfdYUgqMw9NQsiavZ1yfp6nqXs2psvhrv4w9nkv9ZkNrPibvNFjjAjcooyToUBjMt08NnksFDw/132, createdBy=16335154838, createdName=634071814_16358511, createdTime=Wed Oct 23 00:00:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152923, encodeId=83f621529239b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:传染病<br>经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13c8713895, createdName=ms3000000245174331, createdTime=Tue Aug 15 20:34:05 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151570, encodeId=0a4421515e014, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:新冠<br>经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Aug 07 08:21:32 CST 2023, time=2023-08-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143916, encodeId=f6d82143916fe, content=刚投,希望可以送审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=648b5646355, createdName=ms2000001355147229, createdTime=Tue Jun 20 17:15:43 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109115, encodeId=9e772109115a2, content=偏重的研究方向:传染病<br>经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2b8121812, createdName=Lorabetter, createdTime=Fri Jan 06 19:41:12 CST 2023, time=2023-01-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=888810, encodeId=16ca88881092, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:感染;传染病<br>经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1534890747, createdName=2514703170, createdTime=Sun Sep 27 23:18:01 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2019-10-23 634071814_16358511

    版面费多少SSRIs 2014-12-06 10:34:00 发表:
    中过一篇meta,就是版面费略贵。

    SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=949989, encodeId=5c5c949989bf, content=5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Sun Mar 21 21:29:42 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102660, encodeId=2fb8210266076, content=投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Fri Nov 25 22:32:42 CST 2022, time=2022-11-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1224331, encodeId=1391122433133, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染<br>经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f64830584, createdName=263724263, createdTime=Sat Jun 04 02:08:47 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145017, encodeId=1e79214501e9a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:感染学;mNGS<br>经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85a68298213, createdName=ms5000001540302513, createdTime=Tue Jun 27 13:42:09 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578375, encodeId=8cf35e8375b7, content=版面费多少<span class="quote">SSRIs 2014-12-06 10:34:00 发表:<br>中过一篇meta,就是版面费略贵。</span>, beContent=SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTKATfdYUgqMw9NQsiavZ1yfp6nqXs2psvhrv4w9nkv9ZkNrPibvNFjjAjcooyToUBjMt08NnksFDw/132, createdBy=16335154838, createdName=634071814_16358511, createdTime=Wed Oct 23 00:00:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152923, encodeId=83f621529239b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:传染病<br>经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13c8713895, createdName=ms3000000245174331, createdTime=Tue Aug 15 20:34:05 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151570, encodeId=0a4421515e014, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:新冠<br>经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Aug 07 08:21:32 CST 2023, time=2023-08-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143916, encodeId=f6d82143916fe, content=刚投,希望可以送审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=648b5646355, createdName=ms2000001355147229, createdTime=Tue Jun 20 17:15:43 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109115, encodeId=9e772109115a2, content=偏重的研究方向:传染病<br>经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2b8121812, createdName=Lorabetter, createdTime=Fri Jan 06 19:41:12 CST 2023, time=2023-01-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=888810, encodeId=16ca88881092, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:感染;传染病<br>经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1534890747, createdName=2514703170, createdTime=Sun Sep 27 23:18:01 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2023-08-15 ms3000000245174331 来自北京

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:传染病
    经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=949989, encodeId=5c5c949989bf, content=5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Sun Mar 21 21:29:42 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102660, encodeId=2fb8210266076, content=投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Fri Nov 25 22:32:42 CST 2022, time=2022-11-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1224331, encodeId=1391122433133, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染<br>经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f64830584, createdName=263724263, createdTime=Sat Jun 04 02:08:47 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145017, encodeId=1e79214501e9a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:感染学;mNGS<br>经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85a68298213, createdName=ms5000001540302513, createdTime=Tue Jun 27 13:42:09 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578375, encodeId=8cf35e8375b7, content=版面费多少<span class="quote">SSRIs 2014-12-06 10:34:00 发表:<br>中过一篇meta,就是版面费略贵。</span>, beContent=SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTKATfdYUgqMw9NQsiavZ1yfp6nqXs2psvhrv4w9nkv9ZkNrPibvNFjjAjcooyToUBjMt08NnksFDw/132, createdBy=16335154838, createdName=634071814_16358511, createdTime=Wed Oct 23 00:00:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152923, encodeId=83f621529239b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:传染病<br>经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13c8713895, createdName=ms3000000245174331, createdTime=Tue Aug 15 20:34:05 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151570, encodeId=0a4421515e014, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:新冠<br>经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Aug 07 08:21:32 CST 2023, time=2023-08-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143916, encodeId=f6d82143916fe, content=刚投,希望可以送审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=648b5646355, createdName=ms2000001355147229, createdTime=Tue Jun 20 17:15:43 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109115, encodeId=9e772109115a2, content=偏重的研究方向:传染病<br>经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2b8121812, createdName=Lorabetter, createdTime=Fri Jan 06 19:41:12 CST 2023, time=2023-01-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=888810, encodeId=16ca88881092, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:感染;传染病<br>经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1534890747, createdName=2514703170, createdTime=Sun Sep 27 23:18:01 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2023-08-07 刘洋1981 来自浙江省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:新冠
    经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=949989, encodeId=5c5c949989bf, content=5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Sun Mar 21 21:29:42 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102660, encodeId=2fb8210266076, content=投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Fri Nov 25 22:32:42 CST 2022, time=2022-11-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1224331, encodeId=1391122433133, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染<br>经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f64830584, createdName=263724263, createdTime=Sat Jun 04 02:08:47 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145017, encodeId=1e79214501e9a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:感染学;mNGS<br>经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85a68298213, createdName=ms5000001540302513, createdTime=Tue Jun 27 13:42:09 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578375, encodeId=8cf35e8375b7, content=版面费多少<span class="quote">SSRIs 2014-12-06 10:34:00 发表:<br>中过一篇meta,就是版面费略贵。</span>, beContent=SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTKATfdYUgqMw9NQsiavZ1yfp6nqXs2psvhrv4w9nkv9ZkNrPibvNFjjAjcooyToUBjMt08NnksFDw/132, createdBy=16335154838, createdName=634071814_16358511, createdTime=Wed Oct 23 00:00:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152923, encodeId=83f621529239b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:传染病<br>经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13c8713895, createdName=ms3000000245174331, createdTime=Tue Aug 15 20:34:05 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151570, encodeId=0a4421515e014, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:新冠<br>经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Aug 07 08:21:32 CST 2023, time=2023-08-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143916, encodeId=f6d82143916fe, content=刚投,希望可以送审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=648b5646355, createdName=ms2000001355147229, createdTime=Tue Jun 20 17:15:43 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109115, encodeId=9e772109115a2, content=偏重的研究方向:传染病<br>经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2b8121812, createdName=Lorabetter, createdTime=Fri Jan 06 19:41:12 CST 2023, time=2023-01-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=888810, encodeId=16ca88881092, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:感染;传染病<br>经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1534890747, createdName=2514703170, createdTime=Sun Sep 27 23:18:01 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2023-06-20 ms2000001355147229 来自江苏省

    刚投,希望可以送审!

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=949989, encodeId=5c5c949989bf, content=5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Sun Mar 21 21:29:42 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102660, encodeId=2fb8210266076, content=投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Fri Nov 25 22:32:42 CST 2022, time=2022-11-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1224331, encodeId=1391122433133, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染<br>经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f64830584, createdName=263724263, createdTime=Sat Jun 04 02:08:47 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145017, encodeId=1e79214501e9a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:感染学;mNGS<br>经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85a68298213, createdName=ms5000001540302513, createdTime=Tue Jun 27 13:42:09 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578375, encodeId=8cf35e8375b7, content=版面费多少<span class="quote">SSRIs 2014-12-06 10:34:00 发表:<br>中过一篇meta,就是版面费略贵。</span>, beContent=SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTKATfdYUgqMw9NQsiavZ1yfp6nqXs2psvhrv4w9nkv9ZkNrPibvNFjjAjcooyToUBjMt08NnksFDw/132, createdBy=16335154838, createdName=634071814_16358511, createdTime=Wed Oct 23 00:00:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152923, encodeId=83f621529239b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:传染病<br>经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13c8713895, createdName=ms3000000245174331, createdTime=Tue Aug 15 20:34:05 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151570, encodeId=0a4421515e014, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:新冠<br>经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Aug 07 08:21:32 CST 2023, time=2023-08-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143916, encodeId=f6d82143916fe, content=刚投,希望可以送审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=648b5646355, createdName=ms2000001355147229, createdTime=Tue Jun 20 17:15:43 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109115, encodeId=9e772109115a2, content=偏重的研究方向:传染病<br>经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2b8121812, createdName=Lorabetter, createdTime=Fri Jan 06 19:41:12 CST 2023, time=2023-01-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=888810, encodeId=16ca88881092, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:感染;传染病<br>经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1534890747, createdName=2514703170, createdTime=Sun Sep 27 23:18:01 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2023-01-06 Lorabetter 来自上海

    偏重的研究方向:传染病
    经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=949989, encodeId=5c5c949989bf, content=5年间2次投稿均被秒拒,且拒稿理由相同:缺少对照组。但实际上文中对照组非常明确,严重怀疑编辑是否仔细看了投稿内容,或者编辑可能根本不懂统计学,真的很无语。本想发个邮件质询一下,想想还是算了。唉。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Sun Mar 21 21:29:42 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102660, encodeId=2fb8210266076, content=投稿后第一天因为格式问题,编辑返回重投,第二天就with editor,然后四天就Decision in Process,现在又4天了,是不是要被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Fri Nov 25 22:32:42 CST 2022, time=2022-11-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1224331, encodeId=1391122433133, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染<br>经验分享:2021年10月底投稿,一篇临床回顾性研究,也是自己的第一篇SCI,和投稿的第一本期刊。 投稿后一直没有回信,当时以为没戏了。结果3个月后给大修,一位编辑给了二十多条意见,当时看的有点懵,接着反复读自己的文章和这些意见,发现其实他的建议很有价值,也根据他提的问题一一作答;另两位审稿人只提了些语法问题。 1个多月后给小修,又补充了一些内容。因为自己当时在准备考试,延迟了半个月才回复。 1个月后再次小修,发现是同样的问题,后来回想应该是编辑弄错了。还是耐心的回复。 于2022年5月初接受,历时半年多一点。 总的来说,这本英国杂志给人感觉很友好,流程也很清楚。虽然期间有个审稿人回复了一句:the manuscript has no contribution to the industry让人很难受。不过仍然友好地回复希望他能给多一点建议,帮助我们改进论文。 我自己的经验就是,面对审稿人的意见,一定要耐心的回复;我这篇文章里其实有一些硬伤,包括病例数量少,部分数据缺失,但认真地给审稿人解释后,他也没有再揪着这些问题不放,反而是安慰我说,感谢你耐心的解释和反复的修改。我觉得文章最终能接受有一部分原因是自己脸皮足够厚。 前两天听说今年分数暴涨要上十分,既惊喜也后怕,要是今年我可能都不敢投这杂志。感觉自己真的很幸运! 之前选择目标期刊时在梅斯找到很多有建设性的意见,也希望能够回馈一点有价值的东西。 祝大家都心想事成,百发百中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f64830584, createdName=263724263, createdTime=Sat Jun 04 02:08:47 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145017, encodeId=1e79214501e9a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:感染学;mNGS<br>经验分享:刚投稿,6.21号投稿完成,6.22号with editer,6.23号就变成decision in process,到现在还没变,这是要拒稿的话能不能快点,好准备下家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85a68298213, createdName=ms5000001540302513, createdTime=Tue Jun 27 13:42:09 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578375, encodeId=8cf35e8375b7, content=版面费多少<span class="quote">SSRIs 2014-12-06 10:34:00 发表:<br>中过一篇meta,就是版面费略贵。</span>, beContent=SSRIs 2014-12-06 10:34:00 发表: 中过一篇meta,就是版面费略贵。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTKATfdYUgqMw9NQsiavZ1yfp6nqXs2psvhrv4w9nkv9ZkNrPibvNFjjAjcooyToUBjMt08NnksFDw/132, createdBy=16335154838, createdName=634071814_16358511, createdTime=Wed Oct 23 00:00:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152923, encodeId=83f621529239b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:传染病<br>经验分享:8.11.submit,8.14 Decision in Process。难逃被拒的命运。。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13c8713895, createdName=ms3000000245174331, createdTime=Tue Aug 15 20:34:05 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151570, encodeId=0a4421515e014, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:新冠<br>经验分享:这个香港主编好像不喜欢国人的研究,看他们刚发的一篇日本的研究新冠的,然后水平差不多的文章,直接第二天秒拒……明年肯定大幅度降分,有点太拽了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Mon Aug 07 08:21:32 CST 2023, time=2023-08-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143916, encodeId=f6d82143916fe, content=刚投,希望可以送审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=648b5646355, createdName=ms2000001355147229, createdTime=Tue Jun 20 17:15:43 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109115, encodeId=9e772109115a2, content=偏重的研究方向:传染病<br>经验分享:10.24 submit ,10.26 with editor,11.1 under review, 11.21 Required Revision Completed. 11.27 Decision in process. 11.27 Revise. 12.5 submit. 1.3accept.速度很快,编辑效率很高,推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2b8121812, createdName=Lorabetter, createdTime=Fri Jan 06 19:41:12 CST 2023, time=2023-01-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=888810, encodeId=16ca88881092, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:感染;传染病<br>经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1534890747, createdName=2514703170, createdTime=Sun Sep 27 23:18:01 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2020-09-27 2514703170

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:感染;传染病
    经验分享:9.1号投稿,半个月后编辑给大修。审稿人的意见这次很温和,只花了4天的时间就回答完毕,大修修回后6天接受,前后一共22天,效率惊人!

    2

    展开2条回复
共93条页码: 1/10页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分